Glycyrrhiza glabra L. (belonging to the family Leguminosae), commonly known as Licorice, is a popular medicinal plant that has been used in traditional medicine worldwide for its ethnopharmacological efficacy in treating several ailments. Natural herbal substances with strong biological activity have recently received much attention. The main metabolite of glycyrrhizic acid is 18β-glycyrrhetinic acid (18βGA), a pentacyclic triterpene. A major active plant component derived from licorice root, 18βGA has sparked a lot of attention due to its pharmacological properties. The current review thoroughly examines the literature on 18βGA, a major active plant component obtained from Glycyrrhiza glabra L. The current work provides insight into the pharmacological activities of 18βGA and the potential mechanisms of action involved. The plant contains a variety of phytoconstituents such as 18βGA, which has a variety of biological effects including antiasthmatic, hepatoprotective, anticancer, nephroprotective, antidiabetic, antileishmanial, antiviral, antibacterial, antipsoriasis, antiosteoporosis, antiepileptic, antiarrhythmic, and anti-inflammatory, and is also useful in the management of pulmonary arterial hypertension, antipsychotic-induced hyperprolactinemia, and cerebral ischemia. This review examines research on the pharmacological characteristics of 18βGA throughout recent decades to demonstrate its therapeutic potential and any gaps that may exist, presenting possibilities for future drug research and development.

Neuropathic pain affects more than one million people across the globe. The quality of life of people suffering from neuropathic pain has been considerably declining due to the unavailability of appropriate therapeutics. Currently, available treatment options can only treat patients symptomatically, but they are associated with severe adverse side effects and the development of tolerance over prolonged use. In the past decade, researchers were able to gain a better understanding of the mechanisms involved in neuropathic pain; thus, continuous efforts are evident, aiming to develop novel interventions with better efficacy instead of symptomatic treatment. The current review discusses the latest interventional strategies used in the treatment and management of neuropathic pain. This review also provides insights into the present scenario of pain research, particularly various interventional techniques such as spinal cord stimulation, steroid injection, neural blockade, transcranial/epidural stimulation, deep brain stimulation, percutaneous electrical nerve stimulation, neuroablative procedures, opto/chemogenetics, gene therapy, etc. In a nutshell, most of the above techniques are at preclinical stage and facing difficulty in translation to clinical studies due to the non-availability of appropriate methodologies. Therefore, continuing research on these interventional strategies may help in the development of promising novel therapies that can improve the quality of life of patients suffering from neuropathic pain.

The 4-allyl guaiacol is a natural phenolic molecule that has been widely studied for its antioxidant capacity against reactive-oxygen-species-mediated cellular damage. Therefore, we hypothesized that concomitant use of an antioxidant and NSAID may decrease the risk of gastrointestinal toxicity and make the therapy safer. To address the gastrointestinal toxicity of conventional NSAIDs, a new S-naproxen-4-allyl guaiacol chimera (MAS-1696) was computationally developed, chemically synthesized, and tested for anti-inflammatory effectiveness and gastrointestinal safety. The inhibitory potency of MAS-1696 tested against cyclooxygenase-2 (COX2), 15-lipoxygenase-2 (15-LOX2), and lipoxygenase-5 (5-LOX) in vitro revealed a stronger inhibition of COX2. Furthermore, the MAS-1696 chimera increased the COX selectivity index by 23% as compared to the parent compound naproxen, implying higher efficacy and gastric safety. In vivo data showed that MAS-1696 was less likely to cause gastrointestinal harm than naproxen while also exerting anti-inflammatory and analgesic effects equivalent to or superior to naproxen. In conclusion, MAS-1696 is orally active, bio-labile, and crystalline, making it a medication that may be administered orally.

Background/Objectives: Wound healing is a complex process involving inflammation, oxidative stress, immune modulation, and tissue regeneration. Frankincense essential oil (FEO), derived from Boswellia species, is known for its anti-inflammatory, antioxidant, and therapeutic properties. This study investigates the protective effects of FEO in an excision wound model in rats, focusing on oxidative stress reduction, inflammatory cytokine modulation, and caspase-3 regulation. Methods: The chemical composition of FEO was analyzed using gas chromatography-mass spectrometry (GC-MS). Rats with excision wounds were treated with FEO, and its efficacy was assessed using biochemical and histological analyses. Caspase-3 expression, IL-1β, TNF-α, and CD68 levels were measured, along with oxidative stress markers. Wound contraction, epithelialization and collagen synthesis were also evaluated. Immunohistochemical and histopathological assessments were performed to analyze inflammatory infiltration and tissue remodeling. Results: FEO, rich in alpha-phellandrene (10.52%) and limonene (7.31%), significantly downregulated caspase-3, reducing apoptosis in the wound environment. It also lowered IL-1β and TNF-α levels, confirming anti-inflammatory effects. Additionally, FEO modulated CD68 expression, shifting the wound environment from inflammatory to healing. The oil antioxidant activity reduced oxidative stress, limiting caspase-3-mediated apoptosis and enhancing cell survival. FEO treatment accelerated wound contraction, improved epithelialization, and increased collagen synthesis. Histological analysis revealed reduced inflammatory infiltration and enhanced tissue remodeling. Conclusions: FEO integrates anti-inflammatory, antioxidant, and anti-apoptotic mechanisms to promote wound healing and tissue repair. Its ability to modulate caspase-3, IL-1β, TNF-α, CD68, and oxidative stress markers along with its major constituents such as alpha-phellandrene and limonene highlights its potential as a natural therapeutic agent for wound management and regenerative medicine.